- Home
- LSBK vs WHWK Comparison
LSBK vs WHWK Comparison
Compare LSBK & WHWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSBK
- WHWK
- Stock Information
- Founded
- LSBK 1891
- WHWK 2007
- Country
- LSBK United States
- WHWK United States
- Employees
- LSBK N/A
- WHWK N/A
- Industry
- LSBK Savings Institutions
- WHWK Biotechnology: Pharmaceutical Preparations
- Sector
- LSBK Finance
- WHWK Health Care
- Exchange
- LSBK Nasdaq
- WHWK Nasdaq
- Market Cap
- LSBK 90.0M
- WHWK 91.9M
- IPO Year
- LSBK 2006
- WHWK N/A
- Fundamental
- Price
- LSBK $15.93
- WHWK $1.88
- Analyst Decision
- LSBK
- WHWK
- Analyst Count
- LSBK 0
- WHWK 0
- Target Price
- LSBK N/A
- WHWK N/A
- AVG Volume (30 Days)
- LSBK 3.2K
- WHWK 144.7K
- Earning Date
- LSBK 07-23-2025
- WHWK 08-15-2025
- Dividend Yield
- LSBK 3.38%
- WHWK N/A
- EPS Growth
- LSBK 27.62
- WHWK N/A
- EPS
- LSBK 0.89
- WHWK 0.91
- Revenue
- LSBK $25,795,000.00
- WHWK $27,775,000.00
- Revenue This Year
- LSBK N/A
- WHWK $49.83
- Revenue Next Year
- LSBK N/A
- WHWK N/A
- P/E Ratio
- LSBK $17.70
- WHWK $2.09
- Revenue Growth
- LSBK N/A
- WHWK 16.51
- 52 Week Low
- LSBK $11.80
- WHWK $1.21
- 52 Week High
- LSBK $16.95
- WHWK $3.81
- Technical
- Relative Strength Index (RSI)
- LSBK 65.17
- WHWK N/A
- Support Level
- LSBK $15.68
- WHWK N/A
- Resistance Level
- LSBK $15.73
- WHWK N/A
- Average True Range (ATR)
- LSBK 0.07
- WHWK 0.00
- MACD
- LSBK -0.01
- WHWK 0.00
- Stochastic Oscillator
- LSBK 80.00
- WHWK 0.00
About LSBK Lake Shore Bancorp Inc.
Lake Shore Bancorp Inc operates as a savings and loan holdings company. The bank's business consists of attracting retail deposits from the general public in the areas surrounding its branch offices and investing those deposits, together with funds generated from operations, in commercial real estate loans, one-to-four family residential mortgage loans, home equity lines of credit and to a lesser extent, commercial business loans, consumer loans, and investment securities. Its revenues are principally derived from interest earned on loans and investment securities.
About WHWK Whitehawk Therapeutics Inc. Common Stock
Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.